Inotek Pharmaceuticals Garners $5,600,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=845397e7-9cc1-4a3a-a09a-89abd061f291&Preview=1
Date
7/19/2011
Company Name
Inotek Pharmaceuticals
Mailing Address
33 Hayden Avenue 2nd Floor Lexington, MA 02421
Company Description
Inotek Pharmaceuticals Corporation is a private, high-growth, development-stage pharmaceutical company founded in 1996. The Company has leveraged its small molecule chemistry expertise to discover and develop a deep pipeline of therapeutics targeting cell death, DNA repair and inflammatory pathways. Inotek’s lead program is focused on blocking the nuclear DNA repair enzyme, poly (ADP-ribose) polymerase (or PARP), that has broad application in a variety of unmet medical needs.
Website
http://www.inotekcorp.com
Transaction Type
Venture Equity
Transaction Amount
$5,600,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
M&A Terms
Venture Investor
Undisclosed